SLC3A2 has been shown to be one of the proteins involved in the polyamine transport pathway in NB, and in combination with DFMO (ODC1 inhibitor), was shown to inhibit tumor development in TH-MYCN transgenic mice [4]. Here, SLC3A2 is linked to neoplasm.